Sept 13, 2016: Lufthansa Cargo has been awarded the CEIV certification by The International Air Transport Association (IATA).
Over recent months, as part of a complex procedure, independent specialists have reviewed the airline’s processes when transporting pharmaceuticals using the Cool/td Active and Cool/td Passive products and have assessed Lufthansa Cargo as exhibiting superior reliability and expertise.
The German airline is now one of only six airlines worldwide to have received this certification for processes throughout the global route network.
The Lufthansa Cargo Cool Center in Frankfurt was also successfully certified. With the 4500 sq. metre-building, Lufthansa Cargo ensures that pharmaceutical shipments are handled reliably and quickly at its home airport.
“Pharmaceutical shipments are extremely challenging and demand maximum reliability from airlines. Adhering to the required temperature is crucial to ensure medication can be used as planned following shipping,” comments Alexis von Hoensbroech, Board Member Product and Sales at Lufthansa Cargo.
With CEIV Pharma (Center of Excellence for Independent Validators in Pharmaceutical Logistics), the IATA airline association has developed a global standard for pharmaceuticals transport for the very first time.
“IATA has created CEIV Pharma to help airlines, handlers and forwarders to be compliant with international regulations and to create one global standard for transporting pharmaceuticals,” said Glyn Hughes, IATA Global Head of Cargo.
Together with Dokasch, the company even developed the Opticooler – a refrigerated container, which functions exceptionally reliably due to compressor technology (with no need for dry ice).
The Lufthansa Cargo Cool Center, which opened in 2011 offering direct access onto the apron, is one of the most innovative hubs for handling temperature-sensitive cargo across the world. Four cold-storage rooms kept at different temperatures as well as a deep-freeze room ensure that the required temperature is guaranteed for each and every piece of cargo.
“We continue to see good growth opportunities in pharmaceutical shipping,” clarifies von Hoensbroech.
“CEIV certification by IATA – combined with further innovations and product improvements – will help make us an even more attractive proposition to our customers from the pharmaceutical industry. That’s why we will continue to invest in our infrastructure and processes.”